It is what it is. The public does not know about the technology for reasons already stated on this board, e.g., patent protection issues, preventing the scrutiny of critics, journal reviews and write ups, etc. Wall Street would want something they could sink their teeth into, like FDA approval and revenue. We are trading on the OTC Bulletin Board. All of which you already know because you have been following this board.
Patience is going to determine investors riches with Biocurex. I understand your frustration with the pps, as a heavily invested shareholder. Complaining and venting IMO, is counter-productive and pointless because it will change nothing! So I just ride it out and look forward to the promising future.
IMO, there is little chance that Biocurex won't make me a multi-millionare by 2010. This perspective allows me not to trip over the current share price, if anything I wish I had more money to get more at these prices and make me regret that my average pps is so high at .91.
I am surprised that the price has been consistently low like this and that just leads me to believe, again, people don't know about this technology or believe it is too good to be true, especially at these prices. Some are just taking a wait and see approach. The catapult in share price will certainly make headline news when this thing comes together and hits the market!
AI
